NEJM Direct-to-Consumer Ad Study Shows Drug Industry Incapable of Self- Regulation, Says AHF

AIDS Healthcare Foundation (AHF), the US' largest HIV/AIDS healthcare provider, once again denounced direct-to-consumer (DTC) advertising by the pharmaceutical industry after an article published in the New England Journal of Medicine revealed not only an astronomical 330% increase in spending on drug ads over the past ten years ($11.4B up to $29.9B), but also the fact that -- despite the industry's own recommendation to delay ads for new drugs -- most drug company ad campaigns for the most heavily promoted drugs begin within a year after FDA approval. "A Decade of Direct-to-Consumer Advertising of Prescription Drugs," (NEJM, August 16, 2007, Julia M. Donohue, Ph.D., Marisa Cevasco, B.A.,...

Want to see the full article?

• Purchase this article for only $3.00